2023-506367-33-00CompletedPhase 1
A study in healthy people to compare two different tablets of BI 685509 and to test how food and esomeprazole influence the amount of BI 685509 in the blood
Boehringer Ingelheim International GmbH1 site in 1 country16 target enrollmentStarted: December 7, 2023Last updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Enrollment
- 16
- Locations
- 1
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 64 years (18-64 Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
CT Disclosure & Data Transparency
Scientific
Boehringer Ingelheim International GmbH
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Phase 1
A study in healthy people to compare how 2 different formulations of survodutide are taken up by the body2025-522325-35-00Boehringer Ingelheim International GmbH100
Completed
Phase 1
A study in healthy people to compare how 2 different high dose formulations of BI 1015550 are taken up in the body2023-509950-67-00Boehringer Ingelheim International GmbH42
Completed
Phase 1
A study in healthy people to compare how 3 different formulations of survodutide are taken up in the body2024-516529-30-00Boehringer Ingelheim International GmbH30
Completed
Phase 4
A study in healthy people to compare two different Sifrol® tablets2024-510764-23-00Boehringer Ingelheim International GmbH28
Completed
Not Applicable
The comparison study between the healthy persons in middle ages and elderly about lower extremity function and physical activity after total hip arthroplasty(THA) at 10-years.Hip osteoarthritis The healthy persons in middle ages and elderlyJPRN-UMIN000018546Shonan Kamakura Joint Reconstruction Center111